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Function, Structure, and Stability of Enzymes Confined in
Agarose Gels
Jeffrey Kunkel, Prashanth Asuri*
Department of Bioengineering, Santa Clara University, Santa Clara, California, United States of America

Abstract
Research over the past few decades has attempted to answer how proteins behave in molecularly confined or crowded
environments when compared to dilute buffer solutions. This information is vital to understanding in vivo protein behavior,
as the average spacing between macromolecules in the cell cytosol is much smaller than the size of the macromolecules
themselves. In our study, we attempt to address this question using three structurally and functionally different model
enzymes encapsulated in agarose gels of different porosities. Our studies reveal that under standard buffer conditions, the
initial reaction rates of the agarose-encapsulated enzymes are lower than that of the solution phase enzymes. However, the
encapsulated enzymes retain a higher percentage of their activity in the presence of denaturants. Moreover, the
concentration of agarose used for encapsulation had a significant effect on the enzyme functional stability; enzymes
encapsulated in higher percentages of agarose were more stable than the enzymes encapsulated in lower percentages of
agarose. Similar results were observed through structural measurements of enzyme denaturation using an 8anilinonaphthalene-1-sulfonic acid fluorescence assay. Our work demonstrates the utility of hydrogels to study protein
behavior in highly confined environments similar to those present in vivo; furthermore, the enhanced stability of gelencapsulated enzymes may find use in the delivery of therapeutic proteins, as well as the design of novel strategies for
biohybrid medical devices.
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Fewer studies have reported the experimental investigations of
molecular confinement on protein structure and function. In vivo
confinement arises from encapsulation of proteins in spaces only
moderately larger than the proteins (1–50 nm), e.g. ribosome
tunnel or a chaperonin cavity. In vitro investigations of protein
confinement have been achieved by encapsulating proteins in
pores of silica sol-gels, polyacrylamide and agarose gels [14–16], or
by sandwiching them between parallel zirconium layers [17,18].
Eggers and Valentine reported encapsulation of proteins in silica
using the sol-gel method and demonstrated significant enhancements in the thermal stability, possibly arising from the decreased
flexibility of the proteins inside pores of the silica matrix [14].
Bismuto et al. used spectroscopic techniques and molecular
dynamics simulations to explore the correlation between the
structural dynamics and the function and stability of enzymes
encapsulated in agarose gels [16]. Their study indicated that
confinement in agarose gels limits the flexibility of the polypeptide
backbone, thereby preventing protein unfolding at higher
temperatures.
In this study, we investigated the effects of molecular
confinement on enzyme kinetics, as well as their functional and
structural stability under denaturing environments using hydrogel
scaffolds with different porosities and, therefore, different degrees
of confinement. Agarose was used to encapsulate the enzymes of
interest because the pore size of agarose gels can be controlled by
simply changing the concentration of agarose [19,20]. We used

Introduction
It is currently well established that traditional experimental
conditions using dilute buffer solutions cannot accurately predict
behavior of proteins in their in vivo cellular environment [1,2].
Various macromolecules make up more than 60% of the cell
cytosol creating a crowded or confined environment, with
considerably low volumes of free water [1]. Consequently, the
thermodynamics and kinetics of several biological processes in a
living cell, such as rates of protein-catalyzed reactions, proteinprotein interactions, and protein folding and unfolding can be
expected to be quite different from those calculated using
experimental conditions that use proteins in simple dilute buffers
[3].
Recently, several studies have investigated protein behavior
using in vitro conditions that more closely capture the in vivo
cellular environment. Many of these studies have focused on the
use of buffers containing high concentrations of natural and
synthetic macromolecules, such as serum albumin, dextran,
Ficolls, etc. [4–12]. Such macromolecularly crowded systems have
been used to study kinetics of biochemical reactions and networks,
as well as protein unfolding and refolding, and protein association
and aggregation [4,5,8,10,12,13]. Results from these studies have
supported the hypothesis that the excluded volume effects arising
in such crowded environments significantly impact protein fate
and function [4,7,9,11].
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two different concentrations of agarose, 0.5% and 2%, to
encapsulate the enzymes as it has been previously shown that
there is a significant difference in the pore sizes for these
concentrations. Enzymes encapsulated in 2% gels were significantly more stable relative to enzymes encapsulated in 0.5% gels
and solution phase enzymes under denaturing environments,
indicating that increased protein confinement in higher percentage
agarose gels led to greater enhancements in stability. Our data
agrees well with previous investigations of the effects of molecular
confinement on protein structure and function. Furthermore, as
far as we know, this is the first report demonstrating clear
dependence of function and stability of encapsulated proteins on
the degree of confinement. We believe that this ability to control
protein function by simply changing the hydrogel concentration
will significantly impact a variety of industrial and biotechnological
applications.

Figure 1. Functional stability of HRP encapsulated in agarose
gels. Percent activity retained for solution phase HRP (white bars) and
HRP encapsulated in 0.5% agarose (gray bars) and 2% agarose (black
bars) in the presence of 35% ethanol and isopropanol. The relative
activities were calculated by normalizing the activity in the presence of
denaturants to the activity in buffer. Error bars indicate the standard
deviation of triplicate measurements.
doi:10.1371/journal.pone.0086785.g001

Materials and Methods
Materials
The enzymes, horseradish peroxidase (HRP), b-galactosidase
(b-gal), and lysozyme were obtained from Sigma Aldrich (St.
Louis, MO) and used without further purification. The enzyme
substrates
2,29-azinobis(3-ethylbenzthiazoline-6-sulphonate)
(ABTS), hydrogen peroxide, and o-nitrophenyl b-D-galactoside
(ONPG) were also purchased from Sigma Aldrich. Materials for
preparation of the gels, agarose (molecular biology grade) was
obtained from Bio-Rad Laboratories (Hercules, CA), alginic acid
(sodium salt, low viscosity), and calcium chloride were purchased
from Sigma Aldrich. Tris-HCl buffer was obtained from Life
Technologies (Carlsbad, CA). 8-anilino-1-naphthalenesulfonic
acid (ANS), guanidine hydrochloride (GdnHCl), and all other
chemicals were purchased from Sigma Aldrich and used as
received.

formulations were prepared by first combining appropriate
volumes of agarose, alginate, and enzyme stock solutions at
45uC. The mixture was then cooled to room temperature to
solidify agarose, followed by the addition of 200 mL of 100 mM
pH 8.0 Tris-HCl buffer containing 100 mM CaCl2 to crosslink
the alginate. Final alginate concentrations in the hybrid gels were
either 0.5% or 0.25% w/v.

Kinetic Measurement of Enzyme Activity
The initial reaction rates of solution phase and gel-encapsulated
HRP was determined using the ABTS assay; HRP mediates the
oxidation of ABTS in the presence of H2O2 to form a soluble end
product that can be monitored spectrophotometrically at 405 nm.
HRP concentration for the initial rate measurements was 90 nM,
and the ABTS and H2O2 concentrations were 100 mM and
40 mM, respectively. In order to estimate the Michaelis-Menten
kinetic constants KM and Vmax, the concentration of ABTS was
varied between 0–300 mM, while keeping the concentrations of
HRP and H2O2 constant, and the reaction rates were fitted to a
non-linear regression model using GraphPad Prism. b-gal
activities were measured by monitoring the hydrolysis of ONPG
to o-nitrophenol at 420 nm; b-gal concentration was 10 nM and
the ONPG concentration was 80 mM. The spectrophotometric
measurements were made using a Tecan Infinite 200 PRO
spectrophotometer (Durham, NC). Initial rates of ABTS oxidation
and ONPG hydrolysis by agarose gels containing no enzyme were
measured as controls. To determine enzyme activity under
denaturing environments, solution phase and gel-encapsulated
HRP formulations were equilibrated in the denaturant conditions
for 5 minutes, followed by measurement of initial reaction rates.
To check if HRP nonspecifically adsorbs to the agarose gels, 0.5%
and 2% agarose gels were exposed to 90 nM HRP for 30 min
followed by washing in Tris-HCl buffer for 10 min to remove any
unbound or loosely bound enzyme. The activity of the HRPexposed agarose gels were then measured and compared to
agarose gels similarly exposed to Tris-HCl buffer containing no
enzyme and agarose gels containing HRP.

Enzyme Encapsulation in Agarose Gels
The enzymes were encapsulated in agarose using standard
entrapment techniques [16,21,22]. Briefly, solutions of agarose
and enzyme in Tris-HCl buffer (100 mM, pH = 8.0) were
combined at 45uC and the temperature was lowered to room
temperature for solidification of agarose to encapsulate the
enzyme. Stock agarose solutions were prepared by heating
agarose/Tris-HCl buffer mixture at 90uC for 30 minutes. The
agarose stock solutions were then cooled down to and maintained
at 45uC. Freshly prepared enzyme stock solutions in Tris-HCl
buffer were mixed with the agarose solutions at 45uC, aliquots of
the agarose-enzyme solution were then immediately added to
individual wells of a 96-well plate and then cooled to room
temperature. Final agarose gel concentrations were either 2% or
0.5% w/v. Agarose-alginate hybrid gel-encapsulated enzyme
Table 1. Kinetic constants of ABTS oxidation by solution
phase and agarose encapsulated HRP in buffer.

Condition

Vmax (mM s21)

KM (mM)

Solution phase

10.360.3

4.760.2

0.5% agarose

8.660.7

6.460.4

Determination of Enzyme Structure

2% agarose

7.260.6

9.160.6

Structural stability of the solution phase and gel-encapsulated
enzymes was assessed using the ANS fluorescence assay. The
fluorescence measurements were also carried out using the Tecan
Infinite 200 PRO spectrophotometer (Durham, NC). The ANS

The data are the averages of three replicates and the error represents the
standard deviation.
doi:10.1371/journal.pone.0086785.t001
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Figure 2. Kinetic constants of HRP catalysis in presence of denaturants. Relative kinetic constants of ABTS oxidation by solution phase HRP
(white bars) and HRP encapsulated in 0.5% agarose (gray bars) and 2% agarose (black bars) in the presence of 35% ethanol and isopropanol – (a) Vmax
and (b) Vmax/KM. The relative kinetic constants were calculated by normalizing the kinetic parameters of HRP in the presence of denaturants to those
in buffer. Error bars indicate the standard deviation of triplicate measurements.
doi:10.1371/journal.pone.0086785.g002

HRP. The initial rate V0 of agarose-encapsulated HRP relative to
solution phase HRP was ca. 72% for 0.5% AG-HRP and ca. 58%
for 2% AG-HRP, showing the clear dependence of enzymatic
activity on the agarose concentration. Similar effects of agarose
encapsulation on initial reaction rates were also observed for the
unrelated enzyme b-galactosidase (b-gal); the initial rates of b-gal
encapsulated in 0.5% and 2% agarose relative to solution b-gal
were ca. 65% and ca. 54%, respectively. Lower values of initial
rates for enzymes in agarose can be attributed to reduced rates of
protein and substrate diffusion as described using kinetic models of
heterogeneous catalysis. To better understand the role of
encapsulation on enzyme kinetics, we performed experiments to
calculate the apparent values of KM and Vmax for HRP
encapsulated in agarose. Table 1 shows the values obtained for
these parameters for HRP encapsulated in 0.5% and 2% agarose,
as well as for solution phase HRP. We observed a slight decrease
in the values of Vmax and a significant increase in the KM values
for HRP encapsulated in agarose compared to those for solution
phase HRP – especially for 2% AG-HRP. Therefore, these results
suggest that the observed decrease in initial rates for agaroseencapsulated HRP can be attributed to diffusion-controlled
kinetics of the encapsulated enzyme.

fluorescence emission spectra of the enzyme formulations in
standard Tris-HCl buffer conditions and denaturing conditions
were collected after excitation at 360 nm. The final protein
concentration was 40 mg/mL for all the measurements
(HRP = 0.9 mM, b-gal = 0.09 mM, Lysozyme = 2.8 mM), and the
ANS concentration was 13.5 mM. The solution phase and gelencapsulated enzyme formulations were equilibrated in either
Tris-HCl buffer or denaturant conditions for 5 minutes prior to
the fluorescence measurements. Fluorescence spectra of the
agarose or the agarose-alginate hybrid gels containing no enzyme
were recorded similarly and subtracted from the spectra of
enzyme. Furthermore, to check if the hydrogels interfered with the
ANS measurements, fluorescence spectra were also measured for
hydrogels containing the unfolded enzyme-ANS complex (prepared by exposing the unfolded protein to ANS in solution phase
prior to gelation). The spectra for the unfolded enzyme-ANS
complex in 0.5% and 2% agarose were statistically similar to that
in Tris-HCl buffer, indicating no/minimal interference from
agarose.

Results
Kinetic Parameters of HRP Encapsulated in Agarose
Hydrogels

Effect of Agarose Gel Concentration on the Functional
Stability of HRP

In order to study the role of degree of enzyme confinement on
the kinetic parameters, we used agarose to encapsulate the model
enzyme horseradish peroxidase (HRP) that catalyzes the oxidation
of the substrate 2,29-azinobis(3-ethylbenzthiazoline-6-sulphonate)
(ABTS) in the presence of H2O2. Since significant differences in
the average pore radii have been previously reported for 0.5% and
2% agarose gels (ca. 300 nm for 0.5% and ca. 75 nm for 2%
agarose) [19,20], we used these concentrations to generate agarose
gel-encapsulated HRP formulations –0.5% AG-HRP and 2% AG-

Having demonstrated the facile encapsulation of HRP in
agarose and the effects of agarose concentration on enzyme
kinetics under standard buffer conditions, we proceeded to study
the influence of agarose concentration on the stability of the
encapsulated enzymes under denaturing environments. For this,
solution phase and encapsulated HRP were exposed to the
denaturant – ethanol. Initially, we simply compared the initial
rates for solution phase HRP and AG-HRP in standard buffer and
buffer containing 35% ethanol. These studies revealed that while
solution phase HRP only retained a small fraction of its initial
intrinsic activity when exposed to ethanol (ca. 24%), HRP
encapsulated in 0.5% (ca. 55%) and 2% agarose (ca. 73%)
retained a higher percentage of their intrinsic activities (Figure 1).
Similar enhancements in stability for agarose-encapsulated
enzymes were also observed for b-gal formulations exposed to
35% ethanol (Figure S1) and HRP formulations exposed to 35%
isopropanol (Figure 1). In addition, these results also indicate the
role that degree of confinement has on the functional stability of
HRP; specifically, HRP encapsulated in 2% agarose (highly
confined) is significantly more tolerant to the denaturants
compared to HRP encapsulated in 0.5% agarose (less confined).

Table 2. Kinetic constants of ABTS oxidation by solution
phase and agarose encapsulated HRP in 35% ethanol.
Vmax (mM s21)

KM (mM)

Solution phase

1. 360.3

8.160.4

0.5% agarose

3.160.4

8.760.6

2% agarose

5.560.4

11.161.2

Condition

The data are the averages of three replicates and the error represents the
standard deviation.
doi:10.1371/journal.pone.0086785.t002
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Figure 3. Structural stability of enzymes encapsulated in agarose gels. ANS fluorescence intensities (in arbitrary units) for solution phase
enzyme (white) and enzyme encapsulated in 0.5% agarose (gray) and 2% agarose (black) exposed to 35% ethanol – (a) HRP and (b) b-gal.
Fluorescence intensities for the agarose-protein formulations are reported after subtraction of the spectra of the corresponding agarose gels
containing no enzyme.
doi:10.1371/journal.pone.0086785.g003

We performed supplementary experiments to confirm that
molecular confinement, and not nonspecific protein adsorption
to agarose, was responsible for the observed enhancements in
enzyme stability in agarose. Specifically, we compared the
activities of agarose films exposed to either buffer alone or buffer
containing HRP. HRP-exposed agarose films showed negligible
enzymatic activities, thereby suggesting that HRP does not
nonspecifically adsorb to agarose; hence, nonspecific adsorption
can be excluded as the underlying reason for the observed
stabilization effects.
We also calculated the kinetic parameters Vmax and KM for the
AG-HRP formulations and solution phase HRP in the presence of
the denaturants and compared them to the kinetic parameters
obtained in standard buffer (Table 2, Figure 2). In all cases, there
was an increase in the KM values and a decrease in the values of
Vmax in the presence of the denaturants, consistent with previous
observations of the effects on denaturation on enzyme kinetic
parameters [23–25]. However, the effects of the denaturants on
Vmax and KM were less evident for 2% AG-HRP when compared
to 0.5% AG-HRP and solution phase HRP, thus supporting our
initial observations of enhanced functional stability of HRP
encapsulated in 2% agarose under denaturing conditions.

Structural Stability of Agarose Encapsulated HRP
To complement the kinetic assays, we conducted 8-anilino-1naphthalenesulfonic acid or ANS-binding fluorescence assays to
investigate the effect of denaturants on the structural stability of
solution phase and encapsulated HRP. ANS is a fluorescent dye
that has been used widely to probe conformational changes in
proteins; binding of the ANS dye to the exposed hydrophobic
regions of partially folded or fully unfolded proteins is accompanied by a marked increase in the fluorescence intensity and a blue
shift of the peak maximum [26–29]. Consistent with previous
studies using ANS fluorescence assays, when we exposed the
various HRP formulations to the denaturants, we observed
significant increase in the ANS signal, as well as a shift in the
fluorescence emission peak to a broad maximum at 485 nm.
Figure 3a shows the ANS fluorescence intensities of solution phase
HRP and AG-HRP exposed to 35% ethanol. Significant increases
in ANS fluorescence were observed for both solution phase HRP
and 0.5% AG-HRP in 35% ethanol, whereas only a small increase
was observed for 2% AG-HRP. We note that under the tested
conditions, we did not observe an appreciable signal for the HRP
formulations in standard buffer (data not shown). Supplementary
experiments showed that the ANS signal for AG-HRP in ethanol
disappeared when the concentration of ethanol is reduced to ,5%

Figure 4. Structural stability of HRP encapsulated in agarose-alginate hybrid gels. ANS fluorescence intensities (in arbitrary units) for HRP
encapsulated in agarose-alginate hybrid gels exposed to 35% ethanol – (a) 0.5% agarose (gray) and (b) 2% agarose (black) containing 0% (circles),
0.25% (squares), or 0.5% (triangles) alginate. Fluorescence intensities for the agarose-alginate-protein formulations are reported after subtraction of
the spectra of the corresponding agarose-alginate gels containing no enzyme.
doi:10.1371/journal.pone.0086785.g004
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(data not shown), indicating that the ethanol-induced denaturation
of HRP encapsulated in agarose was reversible. The observed
tolerance of 2% AG-HRP to ethanol was not limited to HRP, but
was also observed for two other enzymes, b-gal and lysozyme
(Figure 3b, Figure S2). We also conducted the ANS assays on HRP
formulations in low pH buffers and buffers containing GdnHCl,
and observed similar enhancements in structural stability for 2%
AG-HRP, relative to native and 0.5% AG-HRP (Figure S3).
We performed additional experiments to confirm that the
observed enhancements in the structural stability of 2% AGenzyme formulations were indeed a result of increased protein
confinement in 2% agarose relative to 0.5% agarose. For this, we
exploited the ability of the naturally occurring polysaccharide
alginate to form ionic crosslinked gels in the presence of divalent
calcium ions. Changes in ANS fluorescence were measured for
HRP encapsulated in agarose containing low and high amounts of
alginate. If the increased protein confinement in 2% agarose gels
contributed significantly to enhancements in stability, then HRP
encapsulated in the hybrid gels should be more stable than HRP
encapsulated in pure agarose gels. The specific test conditions
were: HRP encapsulated in 0.5% and 2% agarose gels containing
0.25% or 0.5% alginate; 0.5% AG-HRP and 2% AG-HRP were
used as controls. To prepare the agarose-alginate hybrid gelencapsulated HRP formulations, agarose solutions containing
HRP and alginate were allowed to gel first by lowering the
temperature before the addition of calcium to achieve ionic
crosslinking of alginate. As seen in Figure 4, the ANS signals for
HRP encapsulated in agarose-alginate hybrid gels were lower than
those of HRP encapsulated in pure agarose gels. Furthermore, the
differences in the ANS signal of AG/Alg-HRP relative to AGHRP were more pronounced for 0.5% agarose than observed for
2% agarose. We reason that the degree of confinement of the
enzymes in 2% agarose was already high, and therefore the
addition of alginate resulted in a smaller enhancement in protein
stability relative to the enhancements in stability observed for
0.5% agarose-encapsulated enzymes.

degree of confinement; HRP encapsulated in 2% agarose retained
a greater percentage of enzyme activity and structure, relative to
HRP encapsulated in 0.5% agarose and solution phase HRP,
when exposed to the denaturants used in the study, ethanol and
isopropanol. We hypothesize that the observed enhancements in
stability are due to the lower porosity of 2% agarose gels relative to
0.5% agarose, which leads to a higher degree of protein
confinement for HRP encapsulated in 2% agarose. As a test to
the hypothesis, HRP was encapsulated in a hybrid agarosealginate gel system, and we observed that an additional species,
which would likely contribute to the protein confinement, could
further enhance the structural stability of HRP. These results
support the hypothesis that the increase in observed enhancements
of protein stability for HRP in 2% agarose is due to an increase in
the degree of confinement in higher percentages of agarose.
Data presented in this paper have two main outcomes. First,
from a fundamental standpoint, the data provides a mechanistic
insight into protein behavior in highly confined environments
similar to those experienced by proteins inside living cells. The
current work will guide our future experiments on the use of the
agarose gel-based platforms to explore the effects on molecular
confinement on the kinetics and extent of protein self-association
and aggregation. This is of particular interest as current studies
exploring protein association and aggregation under in vivo-like
conditions have focused on the influence of macromolecular
crowding on the underlying pathways and kinetics [4,5,33]. The
effects of molecular confinement on these protein fates have been
relatively unexplored.
Second, this study also contributes to the development of
applications that use encapsulated proteins; examples include drug
delivery platforms, biosensors, and biofuel cells [34–36]. Encapsulated proteins could also potentially be used for the development
of enzyme bioreactor-based medical devices to assist patients with
kidney and/or liver disease [35,37]. These applications rely on the
long-term operational stability of the encapsulated proteins, and
therefore enhanced stability of proteins encapsulated in agarose as
demonstrated in this paper is of direct relevance to the
applicability of proteins in the biotechnology and biomedical
industries.
In conclusion, our results presented here demonstrate the role of
encapsulation in agarose gels on protein function, structure, and
stability. Analysis of the kinetic constants under standard buffer
conditions suggested that encapsulation of HRP in agarose was
facile and did not lead to significant protein denaturation, and the
enzyme kinetics for agarose-encapsulated HRP was diffusionally
limited. When exposed to denaturing environments, agaroseencapsulated HRP retained a higher percentage of its structure
and function relative to the solution phase enzyme. Furthermore,
HRP encapsulated in 2% agarose (highly confined) is significantly
more resistant to unfolding compared to HRP encapsulated in
0.5% agarose (less confined). Finally, similar trends were also
observed for two other structurally and functionally different
enzymes indicating the generality of the observed phenomenon.
The observed enhancements in stability of enzymes encapsulated
in agarose will be potentially useful in applications ranging from
sensing and diagnostics to drug delivery and medical devices.

Discussion
Several experimental and theoretical reports support the
prevailing concept that both confinement and crowding can
potentially impact protein conformation. A variety of methodologies probing protein conformation have been employed to obtain
mechanistic insights into the effects of different confining
geometries, as well as the result of addition of inert macromolecules to simple dilute buffer solutions. These studies are
significant since many protein functions, including enzymatic
activity and signaling can be directly linked to protein conformation. It is also well appreciated that the conformational changes in
a protein can contribute to its aggregation behavior [30–32].
Recent studies, albeit fewer, have also explicitly attempted to
address the roles of crowding and confinement on protein stability
under denaturing environments; these studies have revealed the
ability of both confinement through encapsulation and crowding
using inert macromolecules to enhance protein conformational
and functional stability [7,9,14,15,18].
In our current study, we have investigated the effects of
molecular confinement on functional and structural stability of
proteins by encapsulating the model enzyme HRP in agarose gels.
Since the porosity of agarose gels and therefore, the degree of
protein confinement in agarose gels is directly related to the
concentration of agarose, this system represents a simple model to
study the effects of confinement on protein structure and function.
Our data revealed a strong dependence of protein stability on the
PLOS ONE | www.plosone.org

Supporting Information
Figure S1 Functional stability of b-gal encapsulated in
agarose gels. Percent activity retained for solution phase b-gal
(white bars) and b-gal encapsulated in 0.5% agarose (gray bars)
and 2% agarose (black bars) in the presence of 35% ethanol. The
relative activities were calculated by normalizing the activity in the
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presence of 35% ethanol to the activity in buffer. Error bars
indicate the standard deviation of triplicate measurements.
(TIFF)

agarose (gray) and 2% agarose (black) exposed to (a) low pH
(pH = 2.8) and (b) 4.7 M GdnHCl. Fluorescence intensities for the
agarose-HRP formulations are reported after subtraction of the
spectra of the corresponding agarose gels containing no enzyme.
(TIFF)

Figure S2 Structural stability of lysozyme encapsulated

in agarose gels. ANS fluorescence intensities (in arbitrary units)
for solution phase lysozyme (white) and lysozyme encapsulated in
0.5% agarose (gray) and 2% agarose (black) exposed to 35%
ethanol. Fluorescence intensities for the agarose-lysozyme formulations are reported after subtraction of the spectra of the
corresponding agarose gels containing no enzyme.
(TIFF)
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